← Company intelligence
Robot maker · early
Andromeda Surgical
Developing the tablet-controlled Beacon robotic platform that automates HoLEP (holmium laser enucleation of the prostate) with AI anatomical mapping and surgeon-in-the-loop autonomy. Running an international clinical trial; urologists in three countries have used it on 40+ patients per company-side coverage. Hospital and clinic buyers pay, so segment is corporate.
HeadquartersSan Francisco, US
Founded2023
Corporate funding$30M
TeamNot listed
Deployments1
Open roles0
01
Company overview
Identity and operating footprint
Company typeRobot maker
Market segmentCorporate
StageSeries A
FoundersNick Damiano (Co-founder & CEO), Kartik Tiwari (Co-founder)
Regions servedUS
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-10-13
LinkedInView profile
XNot listed
MX
Robot models
Specifications remain vendor-claimed
Machinemedical
Beacon
- No specifications on file.
DP
Deployment log
Announced and cited only
CA
Funding history
Publicly announced rounds
Series A
Standard Capital, Y Combinator, VOX Capital
Round sourceInvestors on recordStandard CapitalY CombinatorVOX CapitalLingotto InnovationCybernetix VenturesNZVC
TL
Company timeline
Milestones and announcements
2026-08-03Raised $15M Series A led by Standard Capital; international clinical trial of Beacon underwayRuntime Wire
2026-08-03Andromeda Surgical raises $15 million to bring autonomy to surgery ↗Runtime Wire
SC
Source ledger
2 unique public sources